BioSpace News Archive

CohBar, Inc. announced that The Nasdaq Capital Market has granted the Company’s request for a 180 day extension, or until November 7, 2022, of the period to regain compliance with its minimum bid price per share requirement.

BIORCHESTRA is a leading RNA therapeutics company that develops novel RNA-based therapeutics and drug delivery systems for neurodegenerative diseases.

Aruvant Sciences (“Aruvant”),(SCD) will be presented today in an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) 25th annual meeting.

CSL Limited yesterday announced an update regarding the Vifor Pharma AG acquisition.

Curative Biotechnology Inc., a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced that Cary Sucoff has joined its Board of Directors as an independent director.

SynerFuse™, Inc., a Minneapolis-based medical device company, is pleased to announce the addition of Steven M. Falowski, M.D., F.A.A.N.S., as a strategic advisor.

Volastra Therapeutics , an oncology company focused on exploiting chromosomal instability (CIN) as a vulnerability for cancer cells, today announced that members of its management team are scheduled to participate in a fireside chat at the 2022 Guggenheim Synthetic Lethality Day on May 16th at 11:30 a.m. ET.

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® and J-Plasma® in surgical markets, today reported financial results for its first quarter ended March 31, 2022, and updated financial expectations for the full year ending December 31, 2022.

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the first quarter ended March 31, 2022, and provided a clinical and corporate update.

Virios Therapeutics, Inc. today announced financial results for the first quarter ended March 31, 2022.